Health Ministry bans OTC cough syrups for young children

Decision comes two days after 'Post' queried pharmacy division officials about its use.

August 20, 2007 21:53
1 minute read.
babies 298 aj

babies 298 aj. (photo credit: Ariel Jerozolimski)


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


The Health Ministry on Monday officially recommended that over-the-counter cough syrups not be given to children under the age of two after The Jerusalem Post queried pharmacy division officials about a US Food and Drug Administration advisory on the subject. Until now, giving these syrups to babies was permitted after their first birthday. Three syrups sold here were relevant to these instructions, the ministry said: Symphocal, Tussophedrene COD and the new version of Broncho D. The leaflets accompanying these products currently say they can be given to children over the age of 12 months. It is very important that parents read the leaflets and to use the special measuring spoon included with syrups according to instructions so children are not over-dosed, the ministry said. The use of nonprescription cough syrups containing adrenaline-like pseudoephedrine is much less common in the Israel than in the United States, where there have been reports of 1,500 adverse effects in young patients reaching emergency rooms, including three deaths, and syrups are widely available in supermarkets. Prof. Yona Amitai, a veteran pediatrician and toxicologist who heads the ministry's department of mother and child health, said he would follow the deliberations of a panel of independent experts set to meet on October 18 and to report to the FDA.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

[illustrative photo]
September 24, 2011
Diabetes may significantly increase risk of dementia


Cookie Settings